SCHEMBL7214422

SCHEMBL7214422

COc1cc2c(Nc3cc(O)c(C)cc3F)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.74
RET P07949 4/20 0.73
KIF5B P33176 2/20 0.73
KDR P35968 12/20 0.73
FGFR1 P11362 6/20 0.73
FLT1 P17948 6/20 0.73
FLT4 P35916 4/20 0.73
SRC P12931 9/20 0.69
CIT O14578 1/20 0.66
GAK O14976 1/20 0.66
EPHB6 O15197 1/20 0.66
ABCC4 O15439 1/20 0.66
DAPK3 O43293 1/20 0.66
RIPK2 O43353 1/20 0.66
NR1I2 O75469 1/20 0.66
RPS6KA4 O75676 1/20 0.66
STK17B O94768 1/20 0.66
STK10 O94804 1/20 0.66
PRKD3 O94806 1/20 0.66
ABCB11 O95342 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211048 0.91 EGFR (0.78) EGFRRETKIF5BKDRFGFR1
SCHEMBL7209535 0.87 KDR (0.77) EGFRRETKIF5BKDRFGFR1
SCHEMBL6431249 0.87 RET (0.60) EGFRRETKIF5BKDRFGFR1
SCHEMBL11517 0.86 KDR (0.84) EGFRRETKIF5BKDRFGFR1
Hydrochloric Acid SCHEMBL6434957 0.85 RET (0.58) EGFRRETKIF5BKDRFGFR1
SCHEMBL7859435 0.85 SRC (0.77) EGFRRETKIF5BKDRFLT4
SCHEMBL7867160 0.85 KDR (0.83) EGFRRETKIF5BKDRFGFR1
SCHEMBL6097412 0.85 KDR (0.58) EGFRRETKIF5BKDRFGFR1
SCHEMBL16760462 0.85 RET (1.00) RETKIF5BKDRSRC
Hydrochloric Acid SCHEMBL7866060 0.84 KDR (0.84) EGFRRETKIF5BKDRFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880508-B1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ASTRAZENECA AB (SE) 2003-04-16 EP claimed
US-6184225-B1 ENDOTHELIAL GROWTH FACTOR INHIBITORS, ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2001-02-06 US claimed
EP-0880508-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1998-12-02 EP claimed
WO-1997030035-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1997-08-21 WO claimed
EP-0880508-B1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ASTRAZENECA AB (SE) 2003-04-16 EP disclosed
US-6184225-B1 ENDOTHELIAL GROWTH FACTOR INHIBITORS, ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2001-02-06 US disclosed
EP-0880508-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997030035-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1997-08-21 WO disclosed